Privia Health Group/$PRVA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Privia Health Group

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Ticker

$PRVA
Primary listing

Industry

Health Care Providers & Services

Employees

1,140

ISIN

US74276R1023

PRVA Metrics

BasicAdvanced
$2.7B
183.40
$0.12
0.87
-

What the Analysts think about PRVA

Analyst ratings (Buy, Hold, Sell) for Privia Health Group stock.

Bulls say / Bears say

Privia Health Group reported strong first-quarter 2025 financial results, leading to an upward revision of its full-year 2025 outlook to the mid- to high end of guidance ranges. (Privia Health Newsroom)
The company expanded into Arizona by partnering with Integrated Medical Services, one of the state's largest independent multi-specialty practices, marking its 15th state in the national network. (Privia Health Newsroom)
Analysts have a consensus 'Buy' rating for Privia Health Group, with an average price target of $24.88, indicating confidence in the company's growth prospects. (MarketBeat)
Privia Health Group's profitability is challenged by fragile margins, with a low EBITDA margin of 1.9%, indicating potential financial instability. (MarketScreener)
The company's high P/E ratio of 194.92 suggests that the stock may be overvalued relative to its earnings, posing a risk for investors. (FullRatio)
Analysts have been regularly downgrading their EPS expectations for Privia Health Group over the past 12 months, reflecting concerns about future earnings performance. (MarketScreener)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.

PRVA Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

PRVA Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PRVA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs